Skip to main content

Table 1 Sociodemographic and clinical characteristics

From: Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study

Variables

Percentage or Mean (SD)

Male (n = 2176)

72.2 %

Age (n = 2176)

41.81 (8.94), range 18 - 70

  18-30 years

9.8%

  31-40 years

36.5%

  41-50 years

35.4%

  51-60 years

16.7%

  61-70 years

1.6%

Employment (n = 2168)

 Full time/ education/ training

24.4%

 Part time, regularly

10.1%

 Occasional / Other

13.2%

 Unemployed

52.3%

Having children (n = 1890)

52.4%

Living together with children (n = 2176)

19.7%

Relationship (n = 2158)

 Single

55.2%

 Relationship, not living together

11.5%

 Relationship, living together

33.3%

Own apartment (n = 2163)

83.1%

Migration background (n = 2166)

23.8%

Active drug use (past 12 weeks) (n = 1981)

36.1%

Percentage of positive urine samples (n = 1981)

10.04 (16.79), range 0 - 100

≥ 1 positive urine sample (past 4 weeks)

 Heroin (n = 1605)

16.3%

 Cocaine (n = 1548)

5.3%

 Benzodiazepines (n = 1598)

15.9%

 Amphetamines (n = 1152)

5.3%

Years of opioid dependence (n = 2069)

20.37 (9.11), range 0 - 48

Duration of current OST (years) (n = 2048)

6.25 (5.21), range 0 - 26.5

Substitution medication (n = 2090)

 D-/L-Methadone

76.6% , mean dosage 97.0 (50.1) mg

 Buprenorphine

22.6% , mean dosage 9.8 (6.2) mg

 Other

0.8%

HCV status (n = 1929)

 Anti-HCV negative

43.6%

 RNA negative / Anti-HCV positive

29.4%

 RNA positive

26.9%

HIV positive (n = 1581)

3.7%

HIV/HCV co-infection (n = 1458)

2.2%

  1. Note. Percentages are based on valid numbers, which are indicated in parentheses behind the variables